Biosimilars Quick Guide

Today, there are more effective ways to manage psoriatic disease than ever before. Biologics and biosimilars are systemic treatments that are made from living cells grown in a laboratory and work by targeting specific parts of the immune system that play a role in psoriatic disease.

Get your free resource and learn more about:

  • The difference between biologics and biosimilars
  • Interchangeable products and FDA approval
  • Risks and side effects

Resource last updated: October 2024

Fill out the form below to download your free resource. You will also receive an email with the download link.





Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.